Table 1.

Baseline demographics and history of treatment (n = 99).

Type	Variables	Mean (min, max) or count (%)
Demographics	Age, years	30.92 (18.00–53.00)
	10–20	4 (4.04%)
	20–30	48 (48.48%)
	30–40	38 (38.38%)
	40–50	7 (7.07%)
	50–60	2 (2.02%)
	Gender
	Male	58 (58.59%)
	Female	41 (41.41%)
	Occupation
	Yes	68 (68.69%)
	Marriage
	Yes	19 (19.19%)
	Disease onset
	Adult exacerbation	6 (6.06%)
	Childhood	93 (93.94%)
	Family history of allergy
	Yes	36 (36.36%)
	Allergy history	57 (57.58%)
	Allergic conjunctivitis	17 (29.82%)
	Allergic rhinitis	49 (85.96%)
	Asthma	12 (21.05%)
	Known allergy	55 (55.56%)
	House dust mite	53 (96.36%)
	Mold	19 (34.55%)
	Food	5 (9.09%)
	Cat	6 (10.91%)
	Dog	3 (5.45%)
History of treatment	Topical treatment
	Topical steroid	92 (92.93%)
	Topical calcineurin inhibitor	68 (68.69%)
	Systemic treatment
	Systemic steroid	65 (65.66%)
	Immunosuppressant	61 (61.61%)
	Cyclosporine	53 (86.89%)
	Methotrexate	6 (9.84%)
	Mycophenolate mofetil	1 (1.64%)
	Azathioprine	1 (1.64%)
	Phototherapy	20 (20.20%)
	Immunotherapy	13 (13.13%)
	Oriental medicine	52 (52.53%)
	Folk remedy	27 (27.27%)